Lenograstim and filgrastim effects on neutrophil motility in patients undergoing chemotherapy: evaluation by computer-assisted image analysis

Am J Hematol. 2001 Apr;66(4):306-7. doi: 10.1002/ajh.1064.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bleomycin / administration & dosage
  • CD18 Antigens / biosynthesis
  • Cell Movement / drug effects
  • Chemotaxis, Leukocyte / drug effects*
  • Cyclophosphamide / administration & dosage
  • Cytarabine / administration & dosage
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Filgrastim
  • Glycosylation
  • Granulocyte Colony-Stimulating Factor / chemistry
  • Granulocyte Colony-Stimulating Factor / pharmacology*
  • Humans
  • Image Processing, Computer-Assisted*
  • Lenograstim
  • Lymphoma, Non-Hodgkin / blood*
  • Lymphoma, Non-Hodgkin / drug therapy
  • Methotrexate / administration & dosage
  • Neutrophils / drug effects*
  • Neutrophils / ultrastructure
  • Prednisone / administration & dosage
  • Protein Processing, Post-Translational
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / pharmacology*
  • Vincristine / administration & dosage

Substances

  • CD18 Antigens
  • Recombinant Proteins
  • Cytarabine
  • Bleomycin
  • Granulocyte Colony-Stimulating Factor
  • Vincristine
  • Etoposide
  • Lenograstim
  • Doxorubicin
  • Cyclophosphamide
  • Filgrastim
  • Prednisone
  • Methotrexate

Supplementary concepts

  • PROMACE-CytaBOM protocol